SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Biocept Inc. 
 CA
  SEC # 1044378


        
    Click to view...      Registrant      About      Filings      Files      Relationships      Names    
  Topics  
    Web       

170  Topics
Topic emoji
 within the 

Show:   Most-Recent Document   All Documents   And:   Exhibits  

 As Of  Filing  Doc.  Page    Title Docs.
  In ascending order
8/14/2310-Q1And
4/17/2310-K1Balance Sheets at December 31, 2022 and 2021
1Business
1Certain Relationships and Related Transactions, and Director Independence
1Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
4/17/2310-Q/A1Condensed Balance Sheets as of December 31, 2021 and September 30, 2022 (Unaudited)
8/14/2310-Q1Condensed Balance Sheets as of June 30, 2023
5/10/2310-Q1Condensed Balance Sheets as of March 31, 2023
8/14/2310-Q1Condensed Statements of Cash Flows for the six months ended June 30, 2023 and 2022 (Unaudited)
4/17/2310-Q/A1Condensed Statements of Cash Flows for the three and nine months ended September 30, 2021 and 2022 (Unaudited)
5/10/2310-Q1Condensed Statements of Cash Flows for the three months ended March 31, 2023 and 2022 (Unaudited)
4/17/2310-Q/A1Condensed Statements of Operations for the three and nine months ended September 30, 2021 and 2022 (Unaudited)
8/14/2310-Q1Condensed Statements of Operations for the three and six months ended June 30, 2023 and 2022 (Unaudited)
5/10/2310-Q1Condensed Statements of Operations for the three months ended March 31, 2023 and 2022 (Unaudited)
4/17/2310-Q/A1Condensed Statements of Stockholders' Equity for the three and nine months ended September 30, 2021 and 2022 (Unaudited)
8/14/2310-Q1Condensed Statements of Stockholders' Equity for the three and six months ended June 30, 2023 and 2022 (Unaudited)
5/10/2310-Q1Condensed Statements of Stockholders' Equity for the three months ended March 31, 2023 and 2022 (Unaudited)
8/14/2310-Q1Controls and Procedures
1December 31, 2022
1Defaults Upon Senior Securities
5/25/23424B41Description of Capital Stock
1Description of the Securities We Are Offering
1Dilution
4/17/2310-K1Directors, Executive Officers and Corporate Governance
1Disclosure Regarding Foreign Jurisdiction that Prevent Inspections
1Executive Compensation
8/14/2310-Q1Exhibits
4/17/2310-K1Exhibits, Financial Statement Schedules
5/25/23424B41Experts
8/14/2310-Q1Financial Information
1Financial Statements
4/17/2310-K1Financial Statements and Supplementary Data
1Form 10-K Summary
8/14/2310-Q1Important Note Regarding Forward-Looking Statements
5/25/23424B41Incorporation of Certain Information by Reference
1Legal Matters
8/14/2310-Q1Legal Proceedings
1Management's Discussion and Analysis of Financial Condition and Results of Operations
4/17/2310-K1Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
8/14/2310-Q1Mine Safety Disclosures
1Notes to Condensed Financial Statements (Unaudited)
4/17/2310-K1Notes to Financial Statements
8/14/2310-Q1Other Information
4/20/23S-11Power of Attorney (included on the signature page hereto)
4/17/2310-K1Principal Accounting Fees and Services
1Properties
8/14/2310-Q1Quantitative and Qualitative Disclosures about Market Risk
4/17/2310-K1Report of Independent Registered Public Accounting Firm
1Reserved
8/14/2310-Q1Risk Factors10 
4/17/2310-K1Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
1Signatures
5/25/23424B41Special Note Regarding Forward-Looking Statements
4/17/2310-K1Statements of Cash Flows for the Years Ended December 31, 2022 and 2021
1Statements of Operations and Comprehensive Loss for the Years Ended December 31, 2022 and 2021
1Statements of Operations for the Years Ended December 31, 2022 and 2021
1Statements of Shareholders' Equity for the Years Ended December 31, 2022 and 2021
1Statements of Stockholders' Equity for the Years Ended December 31, 2022 and 2021
5/25/23424B41Summary
1Table of Contents
8/14/2310-Q1Unaudited
5/25/23424B41Underwriting
8/14/2310-Q1Unregistered Sales of Equity Securities and Use of Proceeds
4/17/2310-K1Unresolved Staff Comments
5/25/23424B41Use of Proceeds
1Where You Can Find More Information

Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 7, 10:58:54.2am ET